YZY Med has built a R&D center of 2000㎡ in Wuhan Optics Valley Biomedicine Park, established various technical platforms based on advanced facilities, such as ARMS fluorescent quantitative PCR, multiple fluorescent quantitative PCR, nucleic acid mass spectrometry, fluorescent in situ hybridization(FISH) and circulating tumor cell detection,etc. The company has a 3200㎡of GMP-accredited industrial workshop, obtained the Medical Device Production License by Hubei Food and Drug Administration, and passed the attestation of ISO13485:2016 quality system. The company won the following honorary awards: High-tech Enterprise, National Demonstration Center for Genetic Detection Technology Application, Hubei Demonstration Construction Enterprise on Intellectual Property Right, the third batch of Invisible Champion Cultivation Enterprises in the Subdivision Field of Pillar Industries in Hubei Province, "Enterprise Research and Development Center " in Wuhan.

The company aims to develop various innovative and personalized medical diagnostic products based on the research results of pharmacogenetics and cancer molecular biomarkers. These products can be used clinically to predict the drugs efficacy and determine the durgs dosage by screening the applicable population, thus to develop personalized treatment plans for patients, reduce patient medical costs with improved efficacy and minimize the adverse drug reactions.The purpose of R&D Center is to vigorously advocate international cutting-edge personalized medicine, achieving a modern personalized treatment model:"The right drug for the right patient".